Evofem Biosciences, Inc. financial data

Symbol
EVFM on OTC
Industry
Pharmaceutical Preparations
Location
12400 High Bluff Drive, Suite 600, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Neothetics, Inc. (to 1/5/2018)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 10.8 % -36.4%
Quick Ratio 1.87 % -65.9%
Debt-to-equity -112 % +15.3%
Return On Equity 11.5 %
Return On Assets -61.9 % -126%
Operating Margin -500 % +75.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 100M shares +835%
Common Stock, Shares, Outstanding 100M shares +1666%
Entity Public Float 1.9M USD -97.9%
Common Stock, Value, Issued 10K USD
Weighted Average Number of Shares Outstanding, Basic 96.5M shares +2177%
Weighted Average Number of Shares Outstanding, Diluted 96.5M shares -86.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 100M USD +1470%
Revenue from Contract with Customer, Excluding Assessed Tax 17.1M USD +26.1%
Research and Development Expense 2.58M USD -20.5%
Selling and Marketing Expense 9.6M USD -40.1%
General and Administrative Expense 11.4M USD -23.3%
Costs and Expenses 27.2M USD -32.3%
Operating Income (Loss) -10.1M USD +62.1%
Nonoperating Income (Expense) 2.12M USD -97.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.94M USD -117%
Income Tax Expense (Benefit) -8K USD -173%
Net Income (Loss) Attributable to Parent -7.94M USD -117%
Earnings Per Share, Basic 2.14 USD/shares -99.7%
Earnings Per Share, Diluted 7.05 USD/shares -98.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 639K USD -76.9%
Cash, Cash Equivalents, and Short-term Investments 2.8M USD -93.8%
Accounts Receivable, after Allowance for Credit Loss, Current 5.39M USD -14.7%
Inventory, Net 1.46M USD -42.1%
Assets, Current 8.58M USD -25.5%
Property, Plant and Equipment, Net 1.18M USD -27.6%
Operating Lease, Right-of-Use Asset 127K USD -15.9%
Other Assets, Noncurrent 36K USD +2.86%
Assets 23.9M USD +79.7%
Accounts Payable, Current 16.9M USD +4.11%
Employee-related Liabilities, Current 3.22M USD +77%
Accrued Liabilities, Current 5.12M USD +0.47%
Contract with Customer, Liability, Current 4.5M USD
Liabilities, Current 76.3M USD +12.4%
Operating Lease, Liability, Noncurrent 10K USD -23.1%
Other Liabilities, Noncurrent 0 USD
Liabilities 90.1M USD +32.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.71M USD -495%
Retained Earnings (Accumulated Deficit) -895M USD -1.13%
Stockholders' Equity Attributable to Parent -70.9M USD -25.8%
Liabilities and Equity 23.9M USD +79.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 123K USD
Net Cash Provided by (Used in) Financing Activities 1.7M USD -88.8%
Net Cash Provided by (Used in) Investing Activities -14K USD -367%
Common Stock, Shares Authorized 3B shares 0%
Common Stock, Shares, Issued 100M shares +1666%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 109K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 722K USD +76.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 500K USD
Deferred Tax Assets, Valuation Allowance 145M USD +2%
Deferred Tax Assets, Gross 145M USD +1.32%
Operating Lease, Liability 126K USD -16.6%
Depreciation 12K USD -95.1%
Payments to Acquire Property, Plant, and Equipment 14K USD +367%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9.35M USD -198%
Lessee, Operating Lease, Liability, to be Paid 133K USD -19.4%
Property, Plant and Equipment, Gross 1.88M USD -32.9%
Operating Lease, Liability, Current 116K USD -15.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8K USD -11.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 86K USD -21.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7K USD -50%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5K USD -99.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 3.05M USD +2.11%
Operating Lease, Payments 64K USD -89.5%
Additional Paid in Capital 825M USD -0.38%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 301K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 905K USD -19.7%
Interest Expense 564K USD -0.18%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%